-
Governance and Nominating Committee
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.'s financial performance into perspective.
Governance and Nominating Committee
Governance and
Nominating Committee
Victor Micati (Chairman)
Robert LeBuhn
Phillip M. Renfro
Robert Salisbury
Charter
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.85 | ||
| Change(%) |  | +0.04 | |
| Volume | 652143 | ||
| 5:37 PM - Mar 09, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
05-14-2009
UCB"s Cimzia® Approved in the...
UCB"s Cimzia® Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis
-- Enzon to receive royalties for PEGylation technology-- -
02-04-2009
Enzon to Present at 11th Annua...
Enzon to Present at 11th Annual BIO CEO & Investor Conference
-
10-30-2007
Enzon Initiates Second Phase 1...
Enzon Initiates Second Phase 1 Study of Its HIF-1 Alpha Antagonist
-
06-01-2009
Enzon Presents Clinical Data f...
Enzon Presents Clinical Data from HIF-1 Alpha Antagonist Study at ASCO
-- First specific HIF-1a inhibitor is well tolerated with early signs of clinical benefit-- -
05-14-2009
UCB"s Cimzia® Approved in the...
UCB"s Cimzia® Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis
-- Enzon to receive royalties for PEGylation technology-- -
03-19-2009
Enzon Treats Patients with Sur...
Enzon Treats Patients with Survivin Antagonist
-- Enzon's compound advances into the clinic for patients with solid tumors and lymphomas-- -
02-12-2008
Enzon Pharmaceuticals to Add N...
Enzon Pharmaceuticals to Add New Independent Director to Board